The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness,Risk,and Treatment: New Resources for Survival (PARTNERS) Program

Abstract

This study tested the hypothesis that patients with PAD have impaired health-related quality of life (HRQoL) to a degree similar to that of patients with other types of cardiovascular disease (other-CVD), and also evaluated the clinical features of PAD associated with impaired HRQoL. This was a cross-sectional study in 350 primary care practice sites nationwide with 6,499 participants. The reference group had no clinical or hemodynamic evidence of PAD or other-CVD; the PAD group had an ankle-brachial index < 0.90 or a prior history of PAD; the other-CVD group had a clinical history of cardiac or cerebral vascular disease (but no PAD), and the combined PAD-other-CVD group included both diagnoses. Individuals were assessed using four HRQoL questionnaires including the Walking Impairment Questionnaire (WIQ), Medical Outcomes Study SF-36 (SF-36), Cantril Ladder of Life and the PAD Quality of Life questionnaire. PAD patients had lower WIQ distance scores than the other-CVD group. Both the PAD and other-CVD groups had significantly lower SF-36 Physical Function scores compared with the reference group. The WIQ revealed that PAD patients were more limited by calf pain, whereas other-CVD patients were more limited by chest pain, shortness of breath and palpitations. In conclusion, in this nationwide study, one of the first to directly compare the HRQoL burden of CVD with that of PAD, the evaluation of PAD in office practice revealed a HRQoL burden as great in magnitude as in patients with other forms of CVD.

Keywords

cardiovascular disease claudication functional status health-related quality of life peripheral arterial disease

References

1 Criqui MH Langer RD Fronek A . Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: 381–86.

2 Regensteiner JG Steiner JF Panzer RJ . Evaluation of walking impairment by questionnaire in patients with peripheral arterial disease. J Vasc Med Biol 1990; 2: 142–152.

3 Revicki DA . Health-related quality of life in the evaluation of medical therapy for chronic illness. J Fam Pract 1989; 29: 377–80.

4 Guyatt GH Feeny DH Patrick DL . Measuring health-related quality of life. Ann Intern Med 1993; 118: 622–29.

5 McDermott MM Greenland P Liu K . Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA 2001; 286: 1599–606.

6 Hirsch AT Criqui MH Treat-Jacobson D . Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286: 1317–24.

7 Ware JE Sherbourne CD . The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 1992; 30: 473–83.

8 McHorney CA Ware JE Raczek AE . The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247–63.

9 Regensteiner JG Steiner JF Hiatt WR . Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg 1996; 23: 104–15.

10.

10 Regensteiner JG Ware JE McCarthy WJ . Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials. J Am Geriatr Soc 2002; 50: 1939–46.

11.

11 Regensteiner JG Hargarten ME Rutherford RB . Functional benefits of peripheral vascular bypass surgery for patients with intermittent claudication. Angiology 1993; 44: 1–10.

12.

12 Cantril H . The pattern of human concerns. Rutgers University Press, 1965.

13.

13 Palmore E Kivett V . Change in life satisfaction: a longitudinal study of persons aged 46--70. J Gerontol 1977; 32: 311–16.

14.

14 Atkinson T . The stability and validity of quality of life measures. Soc Indic Res 1982; 10: 113–32.

15.

15 Palmore E Luikart C . Health and social factors related to life satisfaction. J Health Soc Behav 1972; 13: 68–80.

16.

16 Treat-Jacobson D Halverson SL Ratchford A Regensteiner JG Lindquist R Hirsch AT . A patient-derived perspective of health-related quality of life with peripheral arterial disease. J Nurs Scholarsh 2002; 34: 55–60.

17.

17 Criqui MH Denenberg JO Bird CE Fronek A Klauber MR Langer RD . The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing. Vasc Med 1996; 1: 65–71.

18.

18 Wang JC Criqui MH Denenberg JO McDermott MM Golomb BA Fronek A . Exertional leg pain in patients with and without peripheral arterial disease. Circulation 2005; 112: 3501–508.

19.

19 Pfisterer M Buser P Osswald S . Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial. JAMA 2003; 289: 1117–23.

20.

20 Blumenthal RS Cohn G Schulman SP . Medical therapy versus coronary angioplasty in stable coronary artery disease: a critical review of the literature. J Am Coll Cardiol 2000; 36: 668–73.

21.

21 Oldridge N Guyatt G Jones N . Effects on quality of life with comprehensive rehabilitation after acute myocardial infarction. Am J Cardiol 1991; 67: 1084–89.

22.

22 McDermott MM Liu K Greenland P . Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA 2004; 292: 453–61.

23.

23 Mehta T Venkata SA Chetter I . Disease-specific quality of life assessment in intermittent claudication: review. Eur J Vasc Endovasc Surg 2003; 25: 202–208.

24.

24 Stewart KJ Hiatt WR Regensteiner JG . Exercise training for claudication. N Engl J Med 2002; 347: 1941–51.

25.

25 Spronk S Bosch JL Veen HF . Intermittent claudication: functional capacity and quality of life after exercise training or percutaneous transluminal angioplasty – systematic review. Radiology 2005; 235: 833–42.

26.

26 Klevsgard R Froberg BL Risberg B Hallberg IR . Nottingham Health Profile and Short-Form 36 Health Survey questionnaires in patients with chronic lower limb ischemia: before and after revascularization. J Vasc Surg 2002; 36: 310–17.

27.

27 Hiatt WR Regensteiner JG Creager MA . Propionyl-l-carnitine improves exercise performance and functional status in patients with claudication. Am J Med 2001; 110: 616–22.

28.

28 Dumville JC Lee AJ Smith FB . The health-related quality of life of people with peripheral arterial disease in the community: the Edinburgh Artery Study. Br J Gen Pract 2004; 54: 826–31.

29.

29 Collins TC Petersen NJ Suarez-Almazor M . Ethnicity and peripheral arterial disease. Mayo Clin Proc 2005; 80: 48–54.

30.

30 McDermott MM Mehta S Liu K . Leg symptoms, the ankle--brachial index and walking ability in patients with peripheral arterial disease. J Gen Intern Med 1999; 14: 173–81.